Singh Shipra, Dhiraaj Sanjay, Shamshery Chetna, Singh Shalini, Singh Anjali, Kumar Rajput Abhishek, Mishra Prabhaker
Department of Anaesthesiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
Department of Radiotherapy, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
Indian J Palliat Care. 2024 Jan-Mar;30(1):27-33. doi: 10.25259/IJPC_199_2023. Epub 2024 Feb 16.
Pain is classified as nociceptive, neuropathic, or nociplastic. Neuropathic pain presents as variable phenotypes (characters) based on specific aetiology and pathophysiology. This study aimed to find out among cancer patients the incidence of different phenotypes of neuropathic pain and form specific phenotypic clusters based on the underlying neurophysiology and association of sensory profile with various organ systems - A prospective observational study.
The Institutional Ethical Committee clearance (IEC code: 2020-49-MD-EXP-15) https://ctri.nic.in/Clinicaltrials/showallp.php?mid1=44886&EncHid=88651.15716&userName=CTRI/2020/09/027964 approval was obtained. After written and informed consent, patients of age group 18-80 years, registering in the pain and palliative outpatient department or radiotherapy department with complaints of pain and not taking any anti-neuropathic pain medications, were enrolled. They were assessed using Leeds assessment of neuropathic symptoms and signs (LANSS) pain score, and a score of >12 was eligible for assessment of neuropathic pain phenotypes.
Out of 210 cancer patients complaining of pain, a neuropathic component with LANSS >12 was found in 73 (34.76%). The most predominant phenotypes, allodynia> tingling> pricking = burning, were found in 72.60%, 56.16%, and 43.84% of patients, respectively. Phenotypes were clustered into Nodes 1 and 2 based on clinically significant separation of phenotypes. Node 1 had neuropathic pain of spontaneous origin found predominantly in gastrointestinal tract (GIT) and genitourinary tract (GUT) cancers. Node 2 had stimulus-evoked negative and positive characters which occurred in head and neck, thoracic, and spinal metastatic cancers.
Careful patient assessment reveals the incidence of neuropathic pain in 34.76%; allodynia and tingling astable the most prominent phenotypes. Broadly, sensory characters were clustered into spontaneous and stimulus-evoked sensations with GIT and GUT cancers presenting with Node 1 symptoms.
疼痛分为伤害性疼痛、神经性疼痛或神经可塑性疼痛。神经性疼痛根据特定病因和病理生理学表现为不同的表型(特征)。本研究旨在查明癌症患者中神经性疼痛不同表型的发生率,并基于潜在神经生理学以及感觉特征与各器官系统的关联形成特定的表型集群——一项前瞻性观察性研究。
获得了机构伦理委员会批准(IEC代码:2020 - 49 - MD - EXP - 15)https://ctri.nic.in/Clinicaltrials/showallp.php?mid1=44886&EncHid=88651.15716&userName=CTRI/2020/09/027964。在获得书面知情同意后,纳入年龄在18 - 80岁、在疼痛与姑息门诊或放疗科登记且有疼痛主诉且未服用任何抗神经性疼痛药物的患者。使用利兹神经性症状和体征评估(LANSS)疼痛评分对他们进行评估,评分>12分者有资格评估神经性疼痛表型。
在210例主诉疼痛的癌症患者中,发现73例(34.76%)存在LANSS>12的神经性成分。最主要的表型,即痛觉过敏>刺痛>针刺样疼痛 = 烧灼感,分别在72.60%、56.16%和43.84%的患者中出现。根据表型的临床显著差异,表型被聚类为节点1和节点2。节点1具有主要在胃肠道(GIT)和泌尿生殖道(GUT)癌症中发现的自发性神经性疼痛。节点2具有在头颈部、胸部和脊柱转移性癌症中出现的刺激诱发的阴性和阳性特征。
仔细的患者评估显示神经性疼痛的发生率为34.76%;痛觉过敏和刺痛是最突出的表型。广义而言,感觉特征被聚类为自发性和刺激诱发的感觉,胃肠道和泌尿生殖道癌症表现为节点1症状。